Health

Oxford Scientists Working on Vaccine to Prevent Cancer in People with Genetic Disorder

Affordable Data Plans for MTN, Airtel, Glo, and 9mobile at allmedia24data.com
Oxford Scientists Aim to Develop Vaccine for Genetic Cancer Risk Disorder

September 10, 2024

Researchers at the University of Oxford are embarking on an innovative project to develop a vaccine for Lynch syndrome, a genetic condition that significantly increases the risk of various cancers. Known as LynchVax, the initiative targets individuals with this condition who are predisposed to cancers such as bowel, womb, and ovarian cancer due to a mutation in their DNA repair genes.

Buy Cheapest Data Price
Our Data Prices On JMData:
- MTN SME 1: N255 per 1GB
- MTN SME 2: N259 per 1GB
- Airtel CG: N278 per 1GB
- Glo CG: N230 per 1GB
- 9mobile: N125 per 1GB
Download Our Mobile APP to get started: [JMData] https://play.google.com/store/apps/details?id=com.encrypted.jmdata

JOIN MAJOR TELEGRAM MINING
This Mining is the next after #DOGS, Don't Miss it Out
Use this link below to Join 👇👇👇👇👇
https://t.me/major/start?startapp=5289508979

Lynch syndrome affects approximately one in 400 people in England, with only 5% of those affected being aware of their condition. Each year, it contributes to around 1,100 bowel cancer cases in England, elevating the lifetime risk of developing the disease by up to 80%.

The research team aims to create a vaccine that could potentially train the immune system to identify and destroy pre-cancerous cells, thereby preventing the onset of cancer. By analyzing cells from Lynch syndrome patients that are showing early signs of cancer, scientists will identify potential targets for the vaccine and evaluate its effectiveness.

Professor Simon Leedham, a leading researcher in the project, highlights the significant potential of LynchVax: “While our work is in its early stages, we are hopeful that this vaccine could significantly reduce the risk of multiple cancers in those with Lynch syndrome, potentially improving survival rates.”

The initiative is supported by a £550,000 grant from Cancer Research UK. Michelle Mitchell, Chief Executive of Cancer Research UK, underscores the importance of such projects: “Cancer vaccines are a promising frontier in cancer prevention, and LynchVax represents a crucial step towards a future where cancers linked to Lynch syndrome could be prevented.”

For more details, you can read the full article on BBC Oxfordshire.


GRAND COMBAT Is the Next Mining That I will Advice you to join. DON'T MISS IT OUT

JOIN NOW

https://t.me/grandcombat_bot/start?startapp=lYRFU96I5w



Google News Channel

Follow us on Google News for Latest Headlines


Join Our WhatsApp, Facebook, or Telegram Group For More News, Click This Link Below;

WhatsApp Channel

https://whatsapp.com/channel/0029VaELqhlHVvTXjDnUf80h


WhatsApp Group

https://chat.whatsapp.com/G6Lo3ss6WKLCOqBphZwQGk


Facebook Page

https://facebook.com/allmedia24news


Our Twitter Page

https://www.twitter.com/allmedia24news
Telegram Group

https://t.me/allmedia24

Threads App Official Page

https://www.threads.net/@allmedia24news


Discover more from Allmedia24 News

Subscribe to get the latest posts sent to your email.

Allmedia24 Whatsapp Group

RECEIVE NEWS FROM EMAIL

Leave a Comment

Your email address will not be published. Required fields are marked *

*